▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁still 10.59375
▁is 4.203125
▁considered 5.6875
▁to 1.8466796875
▁be 0.57861328125
▁an 3.130859375
▁issue 4.15234375
▁extreme 11.890625
▁at 5.6953125
▁least 3.11328125
▁among 6.5859375
▁of 5.98046875
▁ 4.58984375
8 3.353515625
% 4.4921875
▁the 4.21484375
▁residents 10.203125
▁of 1.7451171875
▁progress 9.25
ive 1.2353515625
▁countries 9.0390625
. 3.283203125
▁introduction 12.0703125
▁The 5.66796875
▁of 5.796875
▁study 6.65234375
▁the 3.0625
▁describes 10.3046875
▁apparent 11.09375
▁the 2.58203125
▁link 8.9921875
▁between 1.7724609375
▁Chron 8.015625
ic 0.089111328125
▁pain 1.1455078125
▁and 2.15625
▁pain 4.81640625
▁dem 10.5390625
oral 4.125
ization 0.47705078125
. 2.388671875
▁always 9.53125
▁is 3.78125
▁accompanied 7.22265625
▁negative 8.4921875
▁emot 3.3984375
ional 1.216796875
▁by 4.8515625
▁experiences 7.5078125
▁and 3.068359375
▁a 4.4296875
▁blocks 12.0859375
▁person 8.25
’ 22.3125
s 3.642578125
▁ability 7.3359375
▁to 0.896484375
▁receive 7.16015625
▁joy 6.8359375
▁satisfaction 7.59375
▁and 2.09765625
▁from 6.0390625
▁life 3.857421875
. 1.3994140625
▁The 3.166015625
▁research 4.53125
▁investig 6.3203125
ates 1.0048828125
▁the 1.09375
▁of 2.650390625
▁development 7.65625
▁de 6.546875
pression 0.2646484375
▁and 1.84375
▁among 8.234375
▁anx 6.73046875
iety 0.031463623046875
▁patients 6.796875
▁ph 9.6171875
arma 1.822265625
ce 0.266845703125
ut 0.0012750625610351562
ical 0.0611572265625
▁receiving 9.390625
▁and 3.6171875
▁op 7.46484375
io 0.272216796875
ids 1.54296875
▁medical 6.796875
▁mar 6.515625
iju 0.07464599609375
ana 0.0010557174682617188
▁( 6.3515625
MM 1.94140625
) 2.6015625
▁severe 8.6796875
▁as 5.66015625
▁comp 8.828125
ares 6.21484375
▁pain 3.142578125
kill 7.48046875
ers 0.01020050048828125
. 2.44921875
▁It 4.515625
▁the 4.33984375
▁of 3.26171875
▁effic 9.390625
acy 0.0220947265625
▁pres 7.74609375
cri 1.1484375
ptions 0.63623046875
▁and 3.015625
▁exam 6.3984375
ines 0.131591796875
▁the 1.5419921875
▁of 2.43359375
▁possibility 8.5703125
▁post 8.796875
- 1.296875
tre 3.6796875
at 0.0163421630859375
ment 0.061859130859375
▁de 4.13671875
pression 0.1463623046875
. 2.400390625
<0x0A> 2.603515625
There 4.74609375
▁is 1.236328125
▁currently 5.171875
▁a 2.07421875
▁severe 5.84375
▁of 3.7421875
▁lack 5.68359375
▁information 5.07421875
▁about 1.796875
▁the 0.90234375
▁effects 3.25
▁of 0.363525390625
▁op 2.796875
i 4.0859375
ates 0.04840087890625
. 3.01953125
▁manage 12.7734375
▁They 8.40625
▁pain 5.3046875
▁but 6.96484375
▁successfully 10.6796875
, 4.0859375
▁the 2.490234375
▁past 8.0234375
▁few 3.01953125
▁dec 2.123046875
ades 0.0011920928955078125
▁the 3.841796875
▁indicated 9.53125
▁growing 7.03515625
▁concern 4.3046875
▁regarding 3.591796875
▁op 2.755859375
iate 0.53759765625
▁in 5.58984375
▁ab 5.265625
use 0.1422119140625
▁forms 10.4296875
▁of 0.63330078125
▁over 6.3359375
d 0.81494140625
ose 0.1390380859375
▁and 1.6123046875
▁add 2.427734375
iction 0.031005859375
. 0.57421875
▁A 4.875
▁and 5.5234375
▁manage 8.5078125
able 5.46484375
▁more 6.609375
▁sa 9.125
fer 0.03118896484375
▁alternative 4.53515625
▁might 7.609375
▁medical 5.9609375
▁be 4.7890625
▁mar 4.88671875
iju 0.01507568359375
ana 0.002353668212890625
. 2.115234375
▁the 4.44140625
▁However 6.80078125
, 0.3486328125
▁legal 6.35546875
▁status 6.5859375
▁and 3.021484375
▁of 4.32421875
▁this 4.7578125
▁novel 5.7421875
ty 9.484375
▁drug 6.26171875
▁do 6.62890625
▁not 0.92333984375
▁finding 11.34375
▁allow 7.1484375
▁a 4.13671875
▁number 5.66796875
▁large 9.125
▁of 1.9189453125
▁studies 3.99609375
▁on 2.69140625
▁its 1.7890625
▁Specifically 11.8828125
, 0.36474609375
▁effect 8.1171875
iveness 0.73486328125
. 3.802734375
▁it 4.6640625
▁concerns 8.1640625
▁the 2.158203125
▁emot 8.3046875
ional 0.07904052734375
▁condition 6.50390625
▁of 1.0986328125
▁experien 8.421875
cing 0.0258331298828125
▁patients 5.22265625
▁chron 4.21484375
ic 0.0941162109375
▁pain 0.736328125
. 1.7646484375
▁This 4.08984375
▁research 3.962890625
▁to 5.15234375
▁a 4.41796875
ims 3.8671875
▁paper 9.640625
▁analyze 5.99609375
▁levels 9.4296875
▁de 5.578125
pression 0.10064697265625
▁of 3.48828125
▁anx 5.0859375
iety 0.00897216796875
▁and 1.9453125
▁among 6.30859375
▁people 4.8984375
▁receiving 4.21484375
▁by 6.8671875
▁ther 8.265625
apy 0.45166015625
▁the 3.607421875
▁comparing 10.1015625
▁effects 4.75
▁of 1.0341796875
▁ph 5.46484375
arma 0.0992431640625
ce 0.00281524658203125
ut 0.000652313232421875
ical 0.00788116455078125
▁op 2.693359375
io 0.5830078125
ids 0.583984375
▁and 1.7998046875
▁MM 2.818359375
. 1.234375
<0x0A> 1.6865234375
The 1.705078125
▁study 3.068359375
▁was 3.298828125
▁conducted 1.623046875
▁in 1.939453125
▁the 1.5830078125
▁form 5.27734375
▁of 0.423095703125
▁collection 8.8828125
▁and 2.244140625
▁analysis 1.189453125
▁of 0.27734375
▁data 1.4638671875
. 1.8447265625
▁statistical 8.6328125
▁Part 11.0859375
icip 0.19580078125
ants 0.07232666015625
▁were 1.958984375
▁rec 4.10546875
ru 0.01378631591796875
ited 0.0005640983581542969
▁six 8.234375
▁for 6.26171875
▁months 7.890625
▁at 3.775390625
▁two 3.806640625
▁major 5.79296875
▁pain 3.56640625
▁relief 5.51171875
▁in 4.15625
▁cent 4.90234375
ers 0.0615234375
▁Israel 10.3359375
. 1.0947265625
▁The 1.90234375
▁research 2.9140625
ers 2.03125
▁used 3.15234375
▁The 5.26171875
▁De 8.96875
pression 0.04486083984375
▁Module 7.67578125
▁of 1.0966796875
▁the 0.62109375
▁Pat 4.05078125
ient 0.0197296142578125
▁Question 5.1953125
naire 0.0792236328125
▁Health 7.53125
▁and 2.998046875
▁the 2.607421875
▁General 4.15625
ized 1.6904296875
▁Dis 8.546875
order 3.01953125
▁An 4.2578125
x 0.0092926025390625
iety 0.005611419677734375
▁Sc 1.6318359375
ale 0.0155792236328125
▁to 2.5390625
▁evaluate 2.61328125
▁interview 9.578125
▁participants 4.51171875
, 3.73046875
▁their 4.5234375
▁answers 6.609375
, 3.23046875
▁and 1.2314453125
▁conduct 7.33984375
▁the 2.03515625
▁study 2.26953125
. 0.35107421875
▁To 5.4453125
▁specifically 9.28125
▁and 4.25
▁evaluate 5.625
▁compare 9.1484375
▁the 1.0380859375
▁of 3.81640625
▁prob 11.2109375
abilities 0.446044921875
▁de 4.3828125
pression 0.07269287109375
▁anx 4.265625
iety 0.0019474029541015625
▁or 6.79296875
▁the 2.939453125
▁among 6.8359375
▁diverse 9.9453125
▁the 3.955078125
▁groups 4.1875
, 2.55078125
▁study 5.81640625
▁used 2.9765625
▁multiple 5.12890625
▁log 4.578125
istic 0.05926513671875
▁analysis 3.548828125
▁regression 6.60546875
▁and 2.95703125
▁chose 10.265625
▁medical 6.86328125
▁mar 4.55859375
iju 0.00978851318359375
ana 0.0007758140563964844
▁as 2.1875
▁the 1.220703125
▁control 3.18359375
▁group 1.3515625
. 0.385009765625
<0x0A> 0.98828125
This 3.75
▁type 5.875
▁of 0.1788330078125
▁study 1.8623046875
▁is 1.46875
▁the 2.734375
▁most 2.740234375
▁reve 9.0
aling 0.01593017578125
▁inclus 11.1796875
ive 0.126220703125
, 2.96484375
▁and 2.900390625
▁as 5.01953125
▁it 2.625
▁contains 5.12109375
▁direct 7.5
▁a 5.33984375
▁responses 10.25
▁from 2.154296875
▁large 6.52734375
▁of 2.5703125
▁number 4.76953125
▁participants 3.40625
. 2.08984375
▁All 4.640625
▁tools 8.84375
▁in 4.46484375
▁the 0.98876953125
▁form 4.359375
▁and 4.60546875
▁of 4.48046875
▁question 3.568359375
na 0.443603515625
ires 0.00148773193359375
▁scales 11.046875
▁have 3.96875
▁been 0.81494140625
▁already 5.82421875
▁used 1.8935546875
▁and 2.142578125
▁their 4.3671875
▁proved 7.83203125
▁effic 5.19921875
acy 0.004638671875
▁for 3.263671875
▁collect 5.9140625
ing 0.043731689453125
▁analyt 8.8046875
ical 0.320556640625
▁data 0.615234375
. 0.62841796875
▁It 3.783203125
▁helps 5.21484375
▁to 0.7734375
▁system 7.37109375
at 1.3193359375
ize 0.156982421875
▁distinct 10.828125
▁and 3.125
▁class 7.15625
ify 0.2369384765625
▁kinds 7.86328125
▁of 0.2666015625
▁information 3.455078125
▁for 4.03125
▁subsequent 5.29296875
▁un 7.62890625
comp 5.453125
licated 0.10870361328125
▁services 10.296875
. 1.0068359375
▁Thus 4.7890625
, 0.2469482421875
▁research 4.2421875
ers 1.97265625
▁can 2.140625
▁compare 4.58203125
▁effects 4.89453125
▁the 4.62109375
▁of 1.515625
▁medic 4.87890625
ations 1.068359375
▁on 2.19921875
▁patients 2.69140625
▁of 3.4609375
▁age 9.21875
▁diverse 7.79296875
▁groups 2.51171875
, 1.6240234375
▁physical 7.19140625
▁background 7.23046875
s 1.146484375
, 0.493408203125
▁emot 4.9453125
ional 0.0545654296875
▁conditions 2.328125
, 0.60595703125
▁states 6.01171875
, 1.833984375
▁so 5.6328125
▁on 3.951171875
. 0.253662109375
<0x0A> 0.88134765625
The 1.4794921875
▁and 7.91015625
▁analysis 4.484375
▁of 0.859375
▁human 8.5078125
▁any 10.6875
▁reaction 7.1328125
▁has 5.29296875
▁a 3.048828125
▁high 4.0078125
▁potential 4.51171875
▁of 1.9892578125
▁and 5.55859375
▁subject 6.99609375
iveness 2.96484375
▁regarding 7.41796875
▁bias 7.359375
, 2.3359375
▁especially 5.1875
▁in 1.7294921875
▁people 6.21484375
▁severe 8.375
▁pain 2.576171875
▁and 2.8203125
▁un 6.25
stable 2.625
▁emot 2.412109375
ional 0.232421875
▁condition 1.8271484375
. 0.453369140625
▁Perhaps 8.4296875
▁some 5.13671875
▁patients 2.783203125
▁tend 5.11328125
▁to 0.1697998046875
▁ex 3.8125
agger 0.005542755126953125
ate 0.056793212890625
▁their 1.2685546875
▁de 5.578125
press 2.35546875
ive 0.303466796875
▁state 2.9296875
▁or 2.818359375
▁vers 13.078125
a 2.958984375
, 1.3857421875
▁de 7.02734375
- 7.3359375
emph 1.8779296875
as 0.01739501953125
ize 0.2186279296875
▁serious 5.87890625
▁difficulties 6.6015625
. 1.197265625
▁vice 10.484375
▁Because 8.6953125
▁survey 9.25
▁the 3.787109375
▁responses 5.21875
▁were 2.794921875
▁thoroughly 9.1953125
▁anonymous 5.08984375
, 0.626953125
▁the 1.826171875
▁research 2.16015625
ers 0.5380859375
▁were 1.8740234375
▁unable 3.009765625
▁carefully 9.453125
▁to 1.197265625
▁each 9.34375
▁analyze 8.453125
▁patient 4.44921875
’ 24.359375
s 0.190185546875
▁reaction 4.19140625
▁and 2.576171875
▁compare 4.4921875
▁it 2.42578125
▁the 3.8203125
▁to 2.6953125
▁states 8.515625
▁actual 8.3828125
▁condition 3.35546875
. 0.46044921875
▁of 7.3203125
▁More 7.33203125
▁accurate 6.53515625
▁answers 5.4765625
▁could 3.65234375
▁be 1.1904296875
▁by 7.26171875
▁obtained 2.25390625
▁professional 10.2421875
▁via 7.6484375
▁psych 4.25
olog 2.28515625
ists 0.165771484375
▁personal 7.0859375
▁communication 4.6953125
▁behavior 11.1015625
al 1.13671875
▁and 2.669921875
▁analysis 6.9375
. 1.4951171875
▁However 4.03125
, 0.047119140625
▁method 6.953125
▁this 5.4140625
▁of 4.0546875
▁is 2.99609375
▁way 8.2734375
▁research 5.0859375
▁more 6.078125
▁resource 8.125
- 2.453125
int 0.8251953125
ensive 0.0142669677734375
▁and 1.12890625
▁energy 9.0078125
- 0.7939453125
consum 0.36279296875
ing 0.01282501220703125
. 0.67529296875
<0x0A> 0.66552734375
Part 5.84375
icip 0.293701171875
ants 0.130615234375
▁were 1.4921875
▁rec 1.828125
ru 0.0039215087890625
ited 0.00010454654693603516
▁for 2.96484375
▁six 2.859375
▁months 0.354248046875
▁at 0.48486328125
▁major 5.55078125
▁two 5.54296875
▁pain 0.2998046875
▁relief 0.468994140625
▁cent 0.861328125
ers 0.01338958740234375
▁in 0.9794921875
▁Israel 0.270263671875
. 0.1732177734375
▁All 3.79296875
▁patients 2.02734375
▁chron 6.84765625
ic 0.07177734375
▁experienced 6.984375
▁pain 1.5263671875
▁for 4.34375
▁at 1.2734375
▁least 0.0161590576171875
▁ 1.998046875
3 1.33203125
▁months 0.396728515625
. 1.2548828125
▁The 1.603515625
▁study 2.1640625
▁included 2.41015625
▁ 1.029296875
8 3.056640625
9 2.818359375
0 3.595703125
▁participants 1.83203125
, 1.55078125
▁of 2.095703125
▁which 1.15625
▁ 0.392822265625
4 1.8173828125
7 2.44921875
4 2.82421875
▁( 2.00390625
5 0.160400390625
9 10.71875
%) 0.91796875
▁sole 11.203125
ly 0.11505126953125
▁were 2.54296875
▁treated 4.59375
▁with 0.9599609375
▁op 0.81298828125
io 0.69384765625
ids 0.302001953125
, 1.4248046875
▁ 0.79638671875
3 1.1201171875
2 2.09375
9 2.490234375
▁( 0.15869140625
4 1.5068359375
1 1.4052734375
%) 0.093994140625
▁were 1.927734375
▁treated 0.91455078125
▁MM 4.51171875
, 0.58203125
▁with 6.00390625
▁and 3.419921875
▁( 4.44140625
8 4.00390625
. 3.470703125
6 2.697265625
%) 0.58740234375
▁ 4.46484375
7 3.13671875
7 2.595703125
▁acquired 9.96875
▁both 3.11328125
▁( 4.15625
Fe 11.15625
ing 4.73046875
old 0.024688720703125
▁et 1.890625
▁ 5.7109375
2 1.6220703125
0 0.56103515625
1 1.1572265625
7 3.48046875
). 0.388427734375
▁al 10.875
., 3.4453125
▁The 3.71484375
▁ten 9.0859375
▁remaining 8.28125
▁participants 2.052734375
▁who 5.16015625
▁did 2.208984375
▁not 0.1875
▁ph 7.953125
arma 0.2301025390625
ce 0.0213470458984375
ut 0.00037360191345214844
ical 0.10498046875
▁receive 2.48828125
▁op 2.158203125
io 0.12176513671875
ids 0.11614990234375
▁and 1.7001953125
▁mar 4.01171875
iju 0.0123291015625
ana 0.0009851455688476562
▁medical 4.30859375
▁were 2.525390625
▁with 5.65625
dra 0.74658203125
wn 0.0010747909545898438
▁from 0.623046875
▁the 0.297607421875
▁in 6.9921875
▁analysis 6.4140625
▁research 4.76953125
. 0.748046875
▁the 4.578125
▁it 8.4921875
▁Therefore 7.75390625
, 0.09503173828125
▁is 6.70703125
▁not 3.451171875
▁possible 2.08984375
▁to 0.52587890625
▁compreh 6.56640625
ens 0.576171875
ively 0.038330078125
▁compare 2.443359375
▁taking 10.5546875
▁patients 5.62890625
▁medic 6.9765625
ations 0.591796875
▁with 2.43359375
▁those 3.66015625
▁who 2.052734375
▁do 2.671875
▁not 0.192626953125
. 1.328125
<0x0A> 0.499755859375
The 1.2333984375
▁study 1.92578125
▁conducted 4.1953125
▁a 3.51953125
▁type 7.17578125
▁correlation 7.7890625
▁of 2.830078125
▁research 4.96484375
▁variable 7.8203125
▁with 3.4921875
▁measures 6.609375
. 3.287109375
▁It 3.021484375
▁evaluated 5.9296875
▁inter 6.9453125
dep 3.595703125
end 0.003803253173828125
ence 0.061767578125
▁of 1.3251953125
▁the 1.9482421875
▁various 5.27734375
▁factors 2.390625
▁affected 7.890625
▁that 6.41015625
▁the 2.748046875
▁physical 7.109375
▁and 1.20703125
▁emot 0.64453125
ional 0.002201080322265625
▁of 5.04296875
▁condition 3.294921875
▁experien 9.65625
cing 0.0024929046630859375
▁patients 2.31640625
▁chron 1.7861328125
ic 0.0017461776733398438
▁pain 0.330078125
. 0.49072265625
▁For 4.48046875
▁example 1.11328125
, 0.088623046875
▁the 1.646484375
▁survey 6.69921875
▁showed 3.857421875
▁that 0.62646484375
▁of 4.94921875
▁the 2.068359375
▁ratio 9.546875
▁female 9.515625
▁patients 1.853515625
▁was 3.619140625
▁higher 1.794921875
▁remark 11.7421875
ably 0.035125732421875
▁in 2.732421875
▁group 4.74609375
▁the 3.861328125
▁op 3.8125
i 2.97265625
ates 0.0343017578125
▁compared 3.306640625
▁to 0.6748046875
▁the 1.68359375
▁MM 1.1728515625
▁group 1.8115234375
. 0.54248046875
▁In 3.23046875
▁turn 4.2890625
, 0.07025146484375
▁people 6.36328125
▁on 5.140625
▁op 2.234375
i 0.83349609375
ates 0.004611968994140625
▁more 3.828125
▁were 4.5859375
▁likely 4.29296875
▁to 0.285888671875
▁report 3.275390625
▁major 5.98828125
▁dis 4.90234375
orders 1.1962890625
. 2.734375
<0x0A> 2.880859375
The 1.169921875
▁de 5.8671875
press 2.732421875
ive 0.048126220703125
▁question 7.2421875
na 2.232421875
ires 0.0007176399230957031
▁used 3.833984375
▁variable 8.6171875
▁different 6.765625
▁measures 4.375
▁to 2.41015625
▁collect 4.16796875
▁information 2.2265625
. 1.3427734375
▁For 2.748046875
▁example 0.2171630859375
, 0.038360595703125
▁included 8.5625
▁it 5.94921875
▁so 7.3828125
cio 1.2412109375
- 0.4375
dem 0.120849609375
ographic 0.07452392578125
▁compreh 9.53125
ensive 0.259033203125
▁data 2.28125
: 3.935546875
▁gender 2.6171875
, 0.2369384765625
▁country 6.1640625
, 1.1044921875
▁age 0.72119140625
, 0.1767578125
▁of 5.90234375
▁type 5.1015625
▁residence 6.74609375
▁( 3.611328125
urban 2.216796875
/ 2.7421875
r 0.08135986328125
ural 0.0012083053588867188
), 0.296142578125
▁years 5.046875
▁of 0.4560546875
▁and 5.56640625
▁education 1.423828125
, 0.74658203125
▁employ 4.01953125
ment 0.0085296630859375
▁status 1.220703125
. 2.837890625
▁Pat 5.38671875
ients 0.2724609375
▁were 1.8447265625
▁also 1.6962890625
▁asked 0.9638671875
▁their 4.03125
▁about 5.1015625
▁medical 3.47265625
▁history 2.060546875
▁the 6.64453125
▁over 8.5
▁years 5.7734375
▁and 2.9140625
▁the 2.201171875
▁current 4.15625
▁of 3.435546875
▁presence 5.72265625
▁any 4.94921875
▁severe 4.53515625
▁dise 2.658203125
ases 0.0009398460388183594
▁such 4.296875
▁as 0.1614990234375
▁failure 10.9921875
, 1.4716796875
▁heart 2.80859375
▁di 8.546875
ab 0.044921875
etes 0.003940582275390625
, 0.3359375
▁ar 4.2109375
th 0.228515625
rit 0.055450439453125
is 0.0107879638671875
, 0.205810546875
▁and 2.259765625
▁so 2.318359375
▁on 0.1070556640625
. 0.0975341796875
▁The 2.34375
▁third 7.33984375
▁measure 3.359375
▁of 2.0390625
▁question 4.77734375
naire 0.66015625
▁the 3.451171875
▁was 2.427734375
▁indicated 9.828125
▁information 5.6328125
▁by 3.908203125
▁on 6.53125
▁twelve 10.6953125
- 2.9609375
month 1.3359375
▁any 10.0625
▁and 4.265625
▁drug 5.109375
▁lifetime 8.921875
▁and 3.61328125
▁alco 6.48828125
hol 0.0009298324584960938
▁consumption 2.30078125
. 0.58740234375
▁In 3.900390625
▁addition 0.8779296875
, 0.1324462890625
▁the 1.61328125
▁record 8.3203125
▁included 3.3515625
▁a 3.44921875
▁pain 5.51953125
▁measurement 5.12890625
▁scale 1.802734375
▁from 4.32421875
▁ 1.572265625
0 0.54150390625
▁to 0.62939453125
▁ 0.070068359375
1 0.11700439453125
0 0.05279541015625
▁to 4.7734375
▁evaluate 1.677734375
▁dis 6.1015625
com 0.384765625
fort 0.004825592041015625
▁feelings 6.515625
▁during 3.4765625
▁the 0.9765625
▁last 2.00390625
▁month 1.4609375
. 0.439453125
<0x0A> 0.68115234375
Am 6.78125
ong 0.01113128662109375
▁all 2.681640625
▁participants 2.556640625
▁in 3.44921875
▁the 0.42041015625
▁study 0.615234375
, 0.24951171875
▁ 0.947265625
4 1.810546875
2 2.78515625
. 2.48828125
2 2.28515625
% 0.1427001953125
▁from 6.453125
▁suffered 8.2734375
▁de 2.7890625
pression 0.261474609375
, 1.47265625
▁and 2.015625
▁ 0.62841796875
3 1.8232421875
7 2.333984375
% 2.74609375
▁experienced 3.576171875
▁excess 8.8515625
ive 0.171630859375
▁anx 0.476318359375
iety 0.003688812255859375
. 0.4853515625
▁The 1.5927734375
▁pl 10.8125
ur 1.49609375
ality 0.0010557174682617188
▁of 0.50830078125
▁de 3.62890625
press 1.4609375
ive 0.0338134765625
▁dis 2.79296875
orders 0.220703125
▁among 3.869140625
▁patients 1.443359375
▁in 3.794921875
▁the 0.79248046875
▁op 3.078125
i 1.9541015625
ates 0.006175994873046875
, 4.484375
▁medical 5.08984375
▁mar 0.493408203125
iju 0.00794219970703125
ana 9.453296661376953e-05
, 0.8017578125
▁and 0.2822265625
▁mixed 6.03125
▁OP 8.96875
MM 6.265625
▁number 11.3828125
ed 2.95703125
▁groups 8.28125
▁ 3.88671875
5 2.248046875
7 2.73046875
. 0.453857421875
1 1.7265625
%, 0.337158203125
▁ 0.056854248046875
2 2.455078125
2 2.17578125
. 0.09246826171875
3 2.361328125
%, 0.2147216796875
▁and 0.2457275390625
▁respectively 7.44921875
. 1.8349609375
▁ 3.423828125
5 2.392578125
1 2.451171875
. 0.1529541015625
4 2.21484375
%, 0.80078125
▁The 4.54296875
▁pl 4.265625
ur 0.0364990234375
ality 6.723403930664062e-05
▁of 0.1761474609375
▁anx 0.64990234375
iety 0.01151275634765625
▁contained 10.4296875
▁ 1.7998046875
4 1.6142578125
8 2.310546875
. 0.06744384765625
4 2.296875
% 0.50830078125
▁among 1.64453125
▁OP 6.1015625
▁patients 8.9296875
, 0.352783203125
▁MM 3.8046875
▁ 1.8388671875
2 1.5
1 2.1875
. 0.0860595703125
5 2.48046875
% 1.373046875
▁among 4.078125
▁and 4.0234375
▁patients 2.9921875
, 0.95751953125
▁ 2.640625
3 1.7255859375
8 2.7890625
. 0.138916015625
7 2.30859375
% 0.03680419921875
▁OP 6.37890625
MM 0.96923828125
▁among 2.927734375
▁participants 5.359375
. 0.5849609375
▁Pat 5.6015625
ients 0.04559326171875
▁who 2.671875
▁took 2.765625
▁strong 8.3671875
▁op 1.1689453125
i 1.759765625
ates 0.0025653839111328125
▁were 2.005859375
▁to 6.37109375
▁place 7.7421875
▁t 7.28125
ended 1.341796875
▁their 7.0625
▁pain 3.720703125
▁on 5.2109375
▁a 1.8408203125
▁scale 2.693359375
▁of 0.8310546875
▁ 0.468505859375
9 3.49609375
▁to 1.5419921875
▁ 0.129150390625
1 0.06414794921875
0 0.10552978515625
▁( 2.921875
Fe 3.53125
ing 0.02020263671875
old 0.00266265869140625
▁et 0.10009765625
▁al 0.7822265625
., 0.95751953125
▁ 0.08660888671875
2 0.018890380859375
0 0.0009722709655761719
1 0.00955963134765625
7 0.03997802734375
). 0.0963134765625
▁They 4.44140625
▁were 1.404296875
▁also 2.345703125
▁an 7.47265625
gu 5.31640625
ished 0.451171875
▁and 2.466796875
▁em 5.65625
otion 0.155029296875
ally 0.01486968994140625
▁rad 12.1484375
ically 0.082275390625
▁react 6.640625
ed 0.33984375
▁neg 6.19921875
atively 0.00464630126953125
▁almost 8.8125
▁to 2.71484375
▁all 2.521484375
▁survey 4.9765625
▁Pat 12.4140625
ients 0.224609375
▁questions 6.19140625
. 0.82666015625
▁who 10.3671875
▁took 1.5859375
▁only 5.38671875
▁MM 0.77099609375
▁mixed 10.765625
▁or 4.59375
▁medic 6.49609375
ations 0.9599609375
▁course 11.4140625
▁had 3.96484375
▁a 1.7685546875
▁significantly 3.216796875
▁more 3.326171875
▁emot 4.0078125
ional 0.0189208984375
▁state 3.03515625
▁stable 9.6484375
▁and 1.654296875
▁cop 6.85546875
ed 1.46875
▁with 0.9052734375
▁pain 1.7431640625
▁more 2.654296875
▁manage 7.03125
able 0.6396484375
. 0.94970703125
<0x0A> 0.5751953125
One 5.4765625
▁of 0.9521484375
▁major 4.8203125
▁the 4.03125
▁limitations 4.81640625
▁is 3.111328125
▁the 0.9697265625
▁ins 5.37109375
u 0.0255889892578125
fficient 0.120849609375
ly 4.4765625
▁response 7.34375
▁high 7.21484375
▁ 7.0390625
5 2.087890625
7 2.087890625
% 1.0986328125
▁instead 9.8125
▁rate 9.5390625
, 3.474609375
▁ 3.990234375
7 3.380859375
0 2.318359375
% 0.3486328125
▁of 1.3349609375
▁( 6.47265625
Fe 0.8876953125
ing 0.005908966064453125
old 0.0011501312255859375
▁et 0.0206756591796875
▁al 0.07159423828125
., 0.021240234375
▁ 0.04437255859375
2 0.0017557144165039062
0 0.000560760498046875
1 0.0020122528076171875
7 0.01139068603515625
). 0.2066650390625
▁can 9.03125
▁be 1.36328125
▁It 8.734375
▁fairly 9.71875
▁explained 4.4453125
▁by 0.75146484375
▁the 0.859375
▁weak 7.20703125
▁focus 8.6484375
▁of 0.748046875
▁respond 6.24609375
ents 0.1517333984375
▁who 4.296875
▁have 4.33203125
▁overcome 9.0234375
▁pain 2.29296875
▁severe 6.43359375
▁sens 9.34375
ations 1.0
▁episodes 10.3203125
. 1.7685546875
▁and 4.41015625
▁de 4.18359375
press 1.7265625
ive 0.1483154296875
▁It 10.1328125
▁is 1.9462890625
▁not 2.71875
▁clear 4.0703125
▁to 2.83203125
▁how 3.2734375
▁these 5.81640625
▁use 10.984375
▁as 5.54296875
▁statistics 8.3984375
, 3.01171875
▁still 8.53125
▁they 3.771484375
▁may 4.3203125
▁be 1.65625
▁relevant 5.140625
▁for 2.33203125
▁overall 5.91796875
▁the 3.091796875
▁analysis 3.5078125
. 1.48046875
